Literature DB >> 2751329

Management of oesophageal stenosis in epidermolysis bullosa dystrophica.

I B Kern1, M Eisenberg, S Willis.   

Abstract

Seven patients with epidermolysis bullosa dystrophica and chronic and recurrent oesophageal lesions such as spasm, strictures, and complete occlusion were studied. Dysphagia could be cured with drugs if it was caused by bullae formation or spasm. If oesophageal strictures were present, endoscopy and bouginage with corticosteroid prophylaxis during the quiescent phase of the disease was a safe and useful procedure. We have also given corticosteroids, which reduced the oedema caused by bullae formation and oral phenytoin, which reduced epithelial detachment by inhibiting collagenase activity. Verapamil counteracted oesophageal spasm and pureed food during periods of dysphagia reduced blistering of the upper oesophagus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751329      PMCID: PMC1791982          DOI: 10.1136/adc.64.4.551

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Epidermolysis bullosa--new therapeutic approaches.

Authors:  M Eisenberg; L H Stevens; P J Schofield
Journal:  Australas J Dermatol       Date:  1978-04       Impact factor: 2.875

2.  Recessive dystrophic epidermolysis bullosa: evidence for an altered collagenase in fibroblast cultures.

Authors:  E A Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

3.  Five year followup of colonic transplants in patients with epidermolysis bullosa producing esophageal obstruction.

Authors:  R De Leon; L A Mispireta; K B Absolon
Journal:  Med Ann Dist Columbia       Date:  1974-05

4.  Anaesthesia for oesophagoscopy in a child with epidermolysis bullosa--a case report.

Authors:  G C Fisk; I B Kern
Journal:  Anaesth Intensive Care       Date:  1973-05       Impact factor: 1.669

5.  Therapeutic considerations in recessive dystrophic epidermolysis bullosa.

Authors:  E A Bauer; T W Cooper
Journal:  Arch Dermatol       Date:  1981-09

6.  Diagnosing epidermolysis bullosa.

Authors:  R A Eady; M J Tidman
Journal:  Br J Dermatol       Date:  1983-05       Impact factor: 9.302

7.  Dysphagia in children with epidermolysis bullosa.

Authors:  J Katz; J D Gryboski; H M Rosenbaum; H M Spiro
Journal:  Gastroenterology       Date:  1967-02       Impact factor: 22.682

8.  Esophageal involvement in epidermolysis bullosa dystrophica: clinical and roentgenographic manifestations.

Authors:  F P Agha; I R Francis; C N Ellis
Journal:  Gastrointest Radiol       Date:  1983

9.  Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.

Authors:  E A Bauer; T W Cooper; D R Tucker; N B Esterly
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

10.  The effect of verapamil on the lower esophageal sphincter pressure in normal subjects and in achalasia.

Authors:  B S Becker; R Burakoff
Journal:  Am J Gastroenterol       Date:  1983-12       Impact factor: 10.864

View more
  2 in total

Review 1.  Dysphagia in dermatologic disease.

Authors:  R Bübl; B Schön
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 2.  Esophageal manifestations of dermatologic disease.

Authors:  James L Wise; Joseph A Murray
Journal:  Curr Gastroenterol Rep       Date:  2002-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.